LOGIN  |  REGISTER
Terns Pharmaceuticals

Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health

August 12, 2024 | Last Trade: US$383.24 2.49 0.65
  • Whole Health Index is an industry-leading calculation for defining and measuring the most powerful drivers of individual and community health

INDIANAPOLIS / Aug 12, 2024 / Business Wire / The Whole Health Index (WHI), created by Elevance Health, Inc. (NYSE: ELV) physicians, data scientists, and researchers, is a first-of-its-kind assessment of health. Using a scale of 0 to 100, the WHI can evaluate a person or group’s relative health over time and assess the physical, behavioral, and social factors that influence it.

“Understanding a person’s overall health enables tailored solutions that drive positive health outcomes,” said Shantanu Agrawal, MD, Elevance Health Chief Health Officer. “We created the Whole Health Index to help assess health holistically, looking at its most powerful drivers. By establishing a credible measurement of individual and community health, we can inform programs and services that advance greater health and health equity.”

The WHI uses more than 90 data points that fall into broad categories of physical, behavioral, and social health. These data points range from food insecurity, transportation accessibility, and housing instability to preventative dental exams, immunizations, and treatment for mental health outcomes. Learn more about the WHI methodology.

Elevance Health recently provided access to WHI data from a subset of employer health plan members starting with two states, Missouri and Virginia. WHI data is accessible at the county level and always de-identified.

About Elevance Health, Inc.

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve over 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.

photo

photo

photo

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page